| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |